• No results found

Pituitary diseases: long-term clinical consequences Klaauw, A.A. van der

N/A
N/A
Protected

Academic year: 2021

Share "Pituitary diseases: long-term clinical consequences Klaauw, A.A. van der"

Copied!
2
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Pituitary diseases: long-term clinical consequences

Klaauw, A.A. van der

Citation

Klaauw, A. A. van der. (2008, December 18). Pituitary diseases: long-term clinical consequences. Retrieved from https://hdl.handle.net/1887/13398

Version: Corrected Publisher’s Version

License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden Downloaded

from: https://hdl.handle.net/1887/13398

Note: To cite this publication please use the final published version (if applicable).

(2)

Agatha van der Klaauw

Pituitary diseases: long-term clinical consequences Agatha van der Klaauw

Leids Universitair Medisch Centrum, Afdeling Endocrinologie en Metabolisme Agatha van der Klaauw

Referenties

GERELATEERDE DOCUMENTEN

Since expression of Serpins may facilitate the immune escape of HLA positive tumors, we next analysed the effect of Serpin expression on survival in cases with normal/partial

Detection of amyloid plaques in mouse models of Alzheimer’s disease by magnetic resonance imaging.. Apostolova

More precisely, an upper bound for the variance of the test statistic R N ∗ is realized by the one-dimensional Moore-Rayleigh null hypothesis, whose distribution is similar to the

Peripheral blood cells were stained with HLA-A2.1 tetramers containing the tyrosinase368–376 peptide followed by staining with a panel of lineage antibodies, as described in

Blades and blade fragments seem to have been especially used for longitudinal motions, mainly on plant material (7/12). Flake and flake fragments are used in different motions on

This shape also occurs in the combination artefacts (see below). The shape is the result of intensive use in a repetitive abrasive motion, carried out from different angles. In

The metabolic syndrome was scored using the National Cholesterol Education Program-Adult Treatment Panel III (NCEP-ATP III) defi nition in 50 consecutive GHD patients (age 45 ±

In order to diff erentiate between the eff ects of serum estradiol concentrations per se and the route of estrogen administration on IGF-I levels in hypogonadal GH-defi cient